Core Viewpoint - T. Rowe Price Group, Inc. is positioned for potential growth despite recent stock performance challenges, with upcoming earnings expected to show revenue growth while EPS is projected to decline [3][5]. Group 1: Stock Performance - T. Rowe Price's stock closed at $103.28, reflecting a 1.54% increase from the previous day, outperforming the S&P 500's marginal gain of 0.01% [2][5]. - Over the past month, T. Rowe Price shares have declined by 8.8%, underperforming the Finance sector's gain of 1.42% and the S&P 500's increase of 4.83% [2][5]. - The stock price is currently approximately $103.73, with a trading range today between $103.47 and $104.99 [4]. Group 2: Financial Outlook - T. Rowe Price is expected to report an earnings per share (EPS) of $2.43, representing a 5.45% decrease from the same quarter last year [3][5]. - Revenue is anticipated to rise by 2.28% to $1.83 billion compared to the previous year, indicating potential growth in operations [3][5]. Group 3: Market Position - Morgan Stanley has set a price target of $125 for T. Rowe Price, suggesting a potential upside of 21.03% from its current trading price [1][5]. - The company's market capitalization stands at approximately $22.79 billion, with a trading volume of 200,143 shares on the NASDAQ exchange [4].

Company Performance - T. Rowe Price (TROW) closed at $103.28, reflecting a +1.54% change from the previous day, outperforming the S&P 500's daily gain of 0.01% [1] - Over the past month, TROW shares have decreased by 8.8%, underperforming the Finance sector's gain of 1.42% and the S&P 500's gain of 4.83% [1] Upcoming Financial Results - T. Rowe Price is expected to report an EPS of $2.43, which represents a 5.45% decrease from the same quarter last year [2] - The consensus estimate for revenue is $1.83 billion, indicating a 2.28% increase compared to the same quarter of the previous year [2] Annual Forecast - For the entire year, the Zacks Consensus Estimates predict earnings of $9.22 per share and revenue of $7.17 billion, reflecting changes of -1.18% and +1.1% respectively from the previous year [3] Analyst Estimates - Recent adjustments to analyst estimates for T. Rowe Price are important as they indicate changing near-term business trends, with upward revisions suggesting analyst confidence in the company's profitability [4] Zacks Rank and Valuation - T. Rowe Price currently holds a Zacks Rank of 3 (Hold), with a Forward P/E ratio of 11.03, which is lower than the industry average Forward P/E of 11.74 [6] - The Zacks Consensus EPS estimate has increased by 1.11% over the last 30 days [6] PEG Ratio - T. Rowe Price has a PEG ratio of 2.62, compared to the Financial - Investment Management industry's average PEG ratio of 1.18 [7] Industry Overview - The Financial - Investment Management industry is part of the Finance sector and currently holds a Zacks Industry Rank of 86, placing it in the top 35% of over 250 industries [8]

Group 1 - U.S. stocks experienced a rise as investors focused on OpenAI's $500 billion valuation, overlooking the government shutdown [4][5] - The S&P 500 index increased by 0.1%, the Nasdaq Composite rose by 0.4%, and the Dow Jones Industrial Average gained 0.2%, with the S&P 500 and Nasdaq reaching new record highs [4] - OpenAI's recent secondary share sale raised $6.6 billion, contributing to its valuation of $500 billion, with notable investors including Thrive Capital and SoftBank Group [5][6] Group 2 - The high valuation of OpenAI reflects optimism for its future and sustained demand for its products, particularly ChatGPT, which has positively impacted other AI-related companies like Nvidia and AMD [6] - Stock futures for major indices, including the S&P 500 and Nasdaq 100, showed positive movement ahead of the market opening [6] Group 3 - The economic calendar is currently light due to the government shutdown, but upcoming speeches from Federal Reserve officials may provide insights into monetary policy [7][8] - Federal Reserve Vice Chair Philip Jefferson emphasized the need to balance inflation risks with labor market support, while Dallas Fed President Lorie Logan advised caution regarding future rate cuts amid persistent inflation [8]

Core Insights - Healthcare innovation and biotechnology are currently highlighted as promising investment areas, particularly following September's rate cut which has improved prospects for R&D and new drug discoveries driven by AI [1] - Active investing in biotech may outperform passive strategies by leveraging deep analyst expertise to identify firms with strong growth potential, especially in a climate of rising equity uncertainty [1][4] Investment Opportunities - The biotechnology sector has evolved significantly since the mapping of the human genome, with four major modalities—gene therapy, gene editing, oligonucleotide therapies, and targeted protein degradation—driving new drug discoveries [2][3] - Rate cuts facilitate easier borrowing for R&D funding, which is crucial before drug revenues materialize, and also stimulate M&A activity that benefits biotech investments [4] Performance Metrics - The S&P Biotechnology Select Industry Index experienced a decline of approximately 10% in its trailing 12-month value as of June 30, yet the top 10 firms within the index achieved average returns of 145% [4] - Active healthcare and biotech ETFs, such as the T. Rowe Price Health Care ETF (TMED), focus on high-performing companies while avoiding underperformers, charging a fee of 44 basis points [4]

New York, New York, Sept. 30, 2025 (GLOBE NEWSWIRE) -- Oak Hill Advisors (“OHA”) served as Administrative Agent and Lead Left Arranger for a private unitranche financing supporting Francisco Partners’ acquisition of Elite. Elite is a leading provider of mission-critical enterprise resource planning (“ERP”) software and integrated payment solutions for law firms globally. OHA is the largest holder of the newly raised debt facility. This transaction follows OHA’s role as the sole lender for TPG’s carve-out of ...

Listen and subscribe to Decoding Retirement on Apple Podcasts, Spotify, or wherever you find your favorite podcasts. It’s the question nearly everyone asks: How much money do I need to retire? There are plenty of benchmarks. Fidelity, for instance, says you should save 10 times your salary by age 67, while T. Rowe Price recommends 7.5 to 13.5 times your income. But Jean Chatzky, host of the HerMoney podcast, said those rules only scratch the surface. “You and I can throw out rules of thumb until we are ...

Core Viewpoint - T. Rowe Price (TROW) is experiencing a decline in stock performance, underperforming both the S&P 500 and the Finance sector, with upcoming financial results expected to show a decrease in EPS but an increase in revenue compared to the previous year [1][2]. Financial Performance - T. Rowe Price is expected to report an EPS of $2.41, reflecting a decrease of 6.23% from the prior-year quarter [2]. - Revenue is anticipated to be $1.83 billion, indicating a growth of 2.28% compared to the same quarter last year [2]. - For the annual period, earnings are projected at $9.18 per share, down 1.61% from last year, while revenue is expected to reach $7.17 billion, up 1.1% [3]. Analyst Estimates - Recent modifications to analyst estimates for T. Rowe Price are crucial as they indicate changing business trends, with positive changes suggesting a favorable outlook on business health and profitability [4]. - The Zacks Consensus EPS estimate has increased by 0.67% over the past month, and T. Rowe Price currently holds a Zacks Rank of 3 (Hold) [6]. Valuation Metrics - T. Rowe Price is trading at a Forward P/E ratio of 11.41, which is lower than the industry average of 12.3 [7]. - The company has a PEG ratio of 2.71, compared to the Financial - Investment Management industry's average PEG ratio of 1.33 [8]. Industry Context - The Financial - Investment Management industry is ranked 147 out of over 250 industries, placing it in the bottom 41% [8]. - The Zacks Industry Rank indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [9].

Group 1 - Neptune Insurance Holdings plans to raise $350 million through an IPO by offering 18.4 million shares priced between $18 and $20, with all shares being secondary market offerings [1][2] - The company has secured cornerstone investors T. Rowe Price and Alliance Bernstein, who have committed to purchase $75 million worth of shares, representing 21% of the total offering [1] - If priced at the midpoint of the offering range, Neptune Insurance's fully diluted market capitalization would reach $2.8 billion [1] Group 2 - Neptune Insurance operates as a data-driven managing general agent (MGA) focused on providing flood risk mitigation solutions for homeowners and businesses [1][2] - The company does not assume any insurance risk on its balance sheet and does not handle claims processing for the policies it sells [2] - Neptune Insurance was founded in 2017 and reported revenue of $137 million for the 12 months ending June 30, 2025 [2]

Group 1 - Goldman Sachs and T. Rowe Price are planning to introduce new alternative investments for wealthy clients by the end of 2025 and for retirement accounts in 2026 [2] - This initiative reflects a growing trend among financial institutions to diversify investment options for high-net-worth individuals and retirement savings [2] - The announcement follows recent statements from Goldman Sachs regarding their investment strategies and market positioning [3]

Core Insights - The article discusses the impact of tariffs on market performance and highlights the potential of international equities for diversification and upside opportunities [1] - It emphasizes the advantages of active management over passive index-tracking ETFs, particularly in adapting to geopolitical changes [2] - A bottom-up active investment strategy is presented as a means to identify specific opportunities in international markets, rather than relying solely on broad market indices [3] Active Management Advantages - Active management offers flexibility that passive ETFs lack, allowing for adjustments in response to geopolitical or policy changes [2] - The ability to adapt allocations based on market conditions is a significant benefit of active management [2] Bottom-Up Active Approach - A bottom-up strategy involves thorough scrutiny of individual stocks rather than merely tracking market indices [3] - This approach is particularly beneficial in identifying high-conviction investment opportunities in uncertain international markets [3] T. Rowe Price Global Equity ETF (TGLB) - TGLB employs a bottom-up active investment strategy with a competitive fee of 46 basis points, focusing on global and emerging markets equities [4] - The fund combines bottom-up fundamental research with top-down macro data to identify strong investment opportunities [4] - TGLB has achieved a return of 2.4% over the last three months, indicating potential for outperforming passive alternatives [5]